Cytotoxicity of cationic liposomes coated by N-trimethyl chitosan and their in vivo tumor angiogenesis targeting containing doxorubicin

Journal of Applied Polymer Science

Volumn 128, Issue 1, 2013, Pages 21-27

  Guo, Xian Xi ^a   He, Wen ^a   Zhang, Xiao Jie ^b   Hu, Xian Ming ^b  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b WUHAN UNIVERSITY   (China)

Author keywords

cationic liposomes; cytotoxicity; doxorubicin; N trimethyl chitosan; tumor angiogenesis targeting

Indexed keywords

CATIONIC LIPOSOMES; CELL PROLIFERATION RATE; DOXORUBICIN; EVALUATION CRITERIA; FLUORESCEIN ISOTHIOCYANATE; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; IN-VITRO; IN-VIVO; MOUSE-FIBROBLASTS; MTT ASSAYS; PROLIFERATION RATE; QUATERNIZATION; SOLID TUMORS; TAIL VEINS; TUMOR ANGIOGENESIS; TUMOR INHIBITION; TUMOR MODELS; TUMOR TISSUES;

CELL CULTURE; CELL PROLIFERATION; CHITOSAN; CYTOTOXICITY; ENDOTHELIAL CELLS; MAMMALS;

TUMORS;

EID: 84872330203     PISSN: 00218995     EISSN: 10974628     Source Type: Journal    
DOI: 10.1002/app.37701     Document Type: Article

References (24)

1. Marcus, S. S.; Sebastian, S.; Senat, K.; Birgitta, S.; Brita, S.; Michael, T.; Uwe, M.; Kurt, N.; Marc, D., Clin. Cancer Res. 2003, 9, 2335.
2. Senat, K.; Alexander, W.; Martin, E. E.; Marcus, S. S.; Sascha, A. P.; Birgitta, S.; Brita, S.; Michael, T.; Uwe, M.; Kurt, N.; Marc, D., Int. J. Cancer 2003, 105, 561.
3. Sebastian, S.; Martin, E. E.; Birgitta, S.; Brita, S.; Michael, T.; Uwe, M.; Marc, D., Int. J. Cancer 2004, 110, 117.
4. Kalra, A. V.; Campbell, R. B.,; Pharm. Res. 2006, 12, 2809.
5. Schmit-Sody, M.; Stieth, S.; Krasnici, S.; Sauer, B.; Schulze, B.; Teifel, M.; Michaelis, U.; Naujoks, K.; Dellian, M., Clin. Cancer Res. 2003, 9, 35.
6. Thurston, G.; McLean, J. W.; Rizen, M.; Baliuk, P.; Haskell, A.; Murphy, T. J.; Hanahan, D.; Mcdonald, D. M., J. Clin. Invest. 1998, 101, 1401.
7. Krasnici, S.; Werner, A.; Eichhorn, M. E.; Schmitt-Sody, M.; Pahernik, S.; Sauer, B.; Schulze, B.; Teifel, M.; Michaelis, U.; Naujoks, K.; Dellian, M., Int. J. Cancer 2003, 5, 561.
8. Augustin, H. G.; Kozian, D. H.; Johson, R. C., Bioassays 1994, 16, 901.
9. Mounkes, L. C.; Zhong, W.; Cipres-Palacin, G.; Heath, T. D.; Debs, R. J., Biol. Chem. 1998, 273, 164.
10. Ran, S.; He, J.; Huang, X. M.; Soares, M.; Scothom, D.; Thorpe, P. E,. Clin. Cancer Res. 2005, 11, 1151.
11. He, W.; Guo, X. X.; Xiao, L. H.; Feng, M., Int. J. Pharm. 2009, 382, 334.
12. Guo, X. X.; He, W.; Wang, X. Q.; Liu, X. Y.; Hu, X. M., J. Appl. Polym. Sci. 2011, 121, 2149.
13. Dass, C. R., J. Pharm. Pharmacol. 2002, 54, 593.
14. Lv, H. T.; Zhang, S. B.; Wang, B.; Cui, S. H.; Yan, J. J., Controlled Release 2006, 114, 100.
15. Liu, W. G.; Yao, K. D., J. Controlled Release 2002, 83, 1.
16. Florea, B. I.; Thanoum, M.; Junginger, H. F.; Borchard, G. J., Controlled Release 2006, 110, 353.
17. Snyman, D.; Hamman, J. H.; Kotze, J. S.; Rollings, J. E.; Kotze, A. F., Carbohydr. Res. 2001, 50, 145.
18. Hamman, J. H.; Kotze, A. F., Drug Dev. Ind. Pharm. 2001, 27, 373.
19. Wei, N.; Lu, B., Acta Pharm. Sinica 2003, 38, 53.
20. Schiffelers, R. M.; Koning, G. A.; Hagen, T.L. M.; Fens Marcel, H.A. M.; A Schraa, S. J.; Janssen Adrienne, P.C. A.; Kok, R. J.; Molema, G.; Storm, G. J., Controlled Release 2003, 91, 115.
21. Dass, C. R., Int. J. Pharm. 2003, 267, 1.
22. Wu, J.; Lee, A.; Lu, Y. H.; Lee, R.,; Int. J. Pharm. 2007, 337, 329.
23. Campbell, R. B.; Fukumura, D.; Brown, E. B.; Mazzola, L. M.; Izumi, Y.; Jain, R. K.; Torchilin, V. P.; Munn, L. L., Cancer Res. 2002, 62, 6831.
24. Zhao, W.; Ma, H. L.; Qi, X. R., Acta. Pharm. Sinica 2007, 42, 982.